ACRAL LENTIGINOUS MELANOMA - A HISTOLOGICAL TYPE WITHOUT PROGNOSTIC-SIGNIFICANCE

被引:53
作者
CASCINELLI, N
ZURRIDA, S
GALIMBERTI, V
BARTOLI, C
BUFALINO, R
DELPRATO, I
MASCHERONI, L
TESTORI, A
CLEMENTE, C
机构
[1] IST NAZL TUMORI,DIV SURG ONCOL B,I-20133 MILAN,ITALY
[2] IST NAZL TUMORI,DIV DIAGNOST ONCOL,I-20133 MILAN,ITALY
[3] IST NAZL TUMORI,DIV PATHOL & CYTOPATHOL,I-20133 MILAN,ITALY
[4] INFORMAT & STAT LAB,MILAN,ITALY
来源
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY | 1994年 / 20卷 / 12期
关键词
D O I
10.1111/j.1524-4725.1994.tb03711.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Acral lentiginous melanoma (ALM) is reported to have a poorer prognosis than melanomas of other histotypes. OBJECTIVE. The purpose of this paper is to verify if ALMs, per se, have a more aggressive behavior or if the poorer prognosis of these patients is due to a later diagnosis. METHODS. Clinical charts of 165 patients with acrally located melanoma were reviewed as well as all histological slides. In all patients, histotype, Clark's level, Breslow thickness, pigmentation, presence of ulceration, and regression were reported. Mitotic index, vascular invasion, and microscopic satellitosis were also determined. Surival of the 64 patients with ALM was compared with survival observed in the remaining 101 acral (nonlentiginous) melanomas. RESULTS. Melanoma localized at acral sites constitute 8.9% of the 1845 patients with melanoma treated at our Institute from 1975 to 1990. All were Caucasian, 57 were males, and 108 females. Out of the 165 patients with this localization, 64 (38.8%) were classified as ALM. Disease-free and overall survival of the 64 ALM patients were not different at a statistically significant level compared with the areas observed in the other acral non-lentiginous melanoma. CONCLUSION. The survival difference between ALM and other histological types is due to a later diagnosis and not to a more aggressive behavior of ALM.
引用
收藏
页码:817 / 822
页数:6
相关论文
共 21 条
[1]  
ACKERMAN AB, 1982, AM J SURG PATHOL, V6, P733
[2]   MALIGNANT-MELANOMA - A UNIFYING CONCEPT [J].
ACKERMAN, AB .
HUMAN PATHOLOGY, 1980, 11 (06) :591-595
[3]  
ARRINGTON JH, 1977, AM J SURG PATHOL, V1, P130
[4]  
BOOHER RJ, 1957, SURGERY, V2, P1084
[5]  
CLARK WH, 1979, HUMAN MALIGNANT MELA, P109
[6]   ACRAL LENTIGINOUS MELANOMA [J].
COLEMAN, WP ;
LORIA, PR ;
REED, RJ ;
KREMENTZ, ET .
ARCHIVES OF DERMATOLOGY, 1980, 116 (07) :773-776
[7]  
FEIBLEMAN CE, 1980, CANCER-AM CANCER SOC, V46, P2492
[8]   THE CLINICAL-FEATURES OF MALIGNANT-MELANOMA [J].
FRIEDMAN, RJ ;
RIGEL, DS .
DERMATOLOGIC CLINICS, 1985, 3 (02) :271-&
[9]   MELANOTIC WHITLOW (SUBUNGUAL MELANOMA) [J].
GIBSON, SH ;
MONTGOMERY, H ;
WOOLNER, LB ;
BRUNSTING, LA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1957, 29 (02) :119-129
[10]  
Hutchinson J., 1886, BRIT MED J, V1, P491